Protara Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Protara Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Protara Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 20.6M shares, a 81.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 20.6M +9.26M +81.5% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 11.4M +56.9K +0.5% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 11.4M +127K +1.12% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 11.4M +97.5K +0.87% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 11.4M +97.5K +0.87% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 11.3M +50.8K +0.45% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 11.3M +54.8K +0.49% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 11.3M +31.7K +0.28% Dec 31, 2022 10-K 2024-03-13
Q3 2022 11.3M +31.7K +0.28% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 11.3M +23.3K +0.21% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 11.3M +23.3K +0.21% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 11.2M +23.9K +0.21% Dec 31, 2021 10-K 2023-03-08
Q3 2021 11.2M +714K +6.79% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 11.2M +5.39M +92.3% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 11.2M +5.39M +92.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 11.2M +8.58M +327% Dec 31, 2020 10-K 2022-03-09
Q3 2020 10.5M -9.06M -46.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 5.84M -13.7M -70.2% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 5.84M -13.7M -70.2% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 2.63M +2.15M +446% Dec 31, 2019 10-K 2021-03-11
Q3 2019 19.6M +364K +1.89% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 19.6M +1.86M +10.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 19.6M +1.91M +10.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 481K -17.2M -97.3% Dec 31, 2018 10-K 2020-03-20
Q3 2018 19.2M +1.6M +9.09% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 17.7M +107K +0.61% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 17.7M +904K +5.39% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 17.7M +1.07M +6.45% Dec 31, 2017 10-K 2019-03-13
Q3 2017 17.6M +1.04M +6.25% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 17.6M +1.04M +6.3% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 16.8M +263K +1.59% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 16.6M +102K +0.62% Dec 31, 2016 10-K 2018-03-14
Q3 2016 16.6M +103K +0.63% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 16.6M +116K +0.71% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 16.5M +59.2K +0.36% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 16.5M +53K +0.32% Dec 31, 2015 10-K 2017-03-16
Q3 2015 16.5M +16.2M +6749% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 16.5M Jun 30, 2015 10-Q 2015-08-13
Q1 2015 16.4M Mar 31, 2015 10-Q 2015-05-13
Q4 2014 16.4M +16.2M +6756% Dec 31, 2014 10-K 2016-03-14
Q3 2014 241K Sep 30, 2014 10-Q 2014-11-25
Q4 2013 240K Dec 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.